Drugs / Sublingual immunotherapy (SLIT)
Sublingual immunotherapy (SLIT)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01335139 | Mar 2011 → Feb 2015 | seasonal allergic rhinitis | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sublingual immunotherapy (SLIT) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01335139 ↗ |
| Modality | Other / unclassified | “sublingual allergen tablet immunotherapy” NCT01335139 ↗ |